324 related articles for article (PubMed ID: 28707574)
1. Recent Progress of Nano-drug Delivery System for Liver Cancer Treatment.
Zhou F; Teng F; Deng P; Meng N; Song Z; Feng R
Anticancer Agents Med Chem; 2018 Feb; 17(14):1884-1897. PubMed ID: 28707574
[TBL] [Abstract][Full Text] [Related]
2. A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells.
Kaur L; Sohal HS; Kaur M; Malhi DS; Garg S
Anticancer Agents Med Chem; 2020; 20(17):2012-2024. PubMed ID: 32753024
[TBL] [Abstract][Full Text] [Related]
3. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Kamath PR; Sunil D
Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
[TBL] [Abstract][Full Text] [Related]
4. Innovative nano-carriers in anticancer drug delivery-a comprehensive review.
Dong P; Rakesh KP; Manukumar HM; Mohammed YHE; Karthik CS; Sumathi S; Mallu P; Qin HL
Bioorg Chem; 2019 Apr; 85():325-336. PubMed ID: 30658232
[TBL] [Abstract][Full Text] [Related]
5. Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy.
Nogueira-Librelotto DR; Codevilla CF; Farooqi A; Rolim CM
Curr Pharm Des; 2017; 23(3):454-466. PubMed ID: 27784246
[TBL] [Abstract][Full Text] [Related]
6. Cellular and Molecular Targeted Drug Delivery: Nanochemistry in Medical Theranostics.
Yadollahpour A
Curr Top Med Chem; 2020; 20(27):2425-2426. PubMed ID: 33210582
[No Abstract] [Full Text] [Related]
7. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
8. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives.
Lan HR; Wu ZQ; Zhang LH; Jin KT; Wang SB
Curr Top Med Chem; 2020; 20(27):2442-2458. PubMed ID: 32703133
[TBL] [Abstract][Full Text] [Related]
10. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. A drug-loaded nanoscale metal-organic framework with a tumor targeting agent for highly effective hepatoma therapy.
Li YA; Zhao XD; Yin HP; Chen GJ; Yang S; Dong YB
Chem Commun (Camb); 2016 Dec; 52(98):14113-14116. PubMed ID: 27858003
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel-decorated anticancer drug and gold nanoparticles encapsulated apatite carrier for the treatment of liver cancer.
Wan J; Ma X; Xu D; Yang B; Yang S; Han S
J Photochem Photobiol B; 2018 Aug; 185():73-79. PubMed ID: 29870961
[TBL] [Abstract][Full Text] [Related]
14. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
Zhang J; Tang H; Liu Z; Chen B
Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
Ye BL; Zheng R; Ruan XJ; Zheng ZH; Cai HJ
Biochem Biophys Res Commun; 2018 Jan; 495(1):414-420. PubMed ID: 29097204
[TBL] [Abstract][Full Text] [Related]
16. Real-time imaging tracking of a dual-fluorescent drug delivery system based on doxorubicin-loaded globin- polyethylenimine nanoparticles for visible tumor therapy.
Zhang Y; Wei C; Lv F; Liu T
Colloids Surf B Biointerfaces; 2018 Oct; 170():163-171. PubMed ID: 29906701
[TBL] [Abstract][Full Text] [Related]
17. Selenium nanoparticles: potential in cancer gene and drug delivery.
Maiyo F; Singh M
Nanomedicine (Lond); 2017 May; 12(9):1075-1089. PubMed ID: 28440710
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
19. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
20. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]